The method of intravenous laser blood irradiation was first introduced as an effective therapy by the Soviet scientists E.N.Meschalkin and V.S.Sergiewski in 1981. Originally this method was developed for the treatment of cardiovascular diseases. Improvement of rheologic properties of the blood as well as improvement of microcirculation and reduction of the area of infarction had been proved. Further reductions of dysrhythmia and sudden cardiac death occurred in subsequent studies . The studies were published mainly in Russian which were little known in the West because of decades of political separation, and were regarded with disapproval. Besides clinical research and application for patients the cell biological basis was developed by the Estonian cell biologist Tiina Karu at the same time.
Intravenous laser therapy is based on the biologic healing action of soft lasers that stimulates the immune system, improves the blood circulation, shows anti-inflammatory effects and activates both the cell metabolism and the production of new cells.
Flowing blood cells are directly radiated with laser light of different wavelengths (red, green, blue) via a sterile single-use laser fiber that is inserted into the arm vein with a cannula.
Light quanta are absorbed by blood cells; this process sets off the described positive biostimulatory reactions and also activates the antioxidant enzyme system.
Patients are treated while lying down or sitting in recumbent or sitting position. The procedure takes between 15 and 20 minutes.
Intravenous laser therapy can be perfectly used to treat chronic diseases that are connected with a weakness of the immune system, of different organ systems or of the metabolism.
Here are some examples:
Furthermore, intravenous laser therapy can perfectly be used in preventive treatment to stay physically fit and for anti-aging purposes.